Christopher Thomas Giordano
CEO, Director · TENAX THERAPEUTICS, INC.
- 2024
- Sep 16, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Christopher Thomas Giordano files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ADAR1 Capital Management, LLC - $4.80M in TENX purchases and sales in the last 12 months
- Declan Doogan - $102K in TENX purchases and sales in the last 12 months
- Thomas McGauley - $58K in TENX purchases and sales in the last 12 months
- Stuart Rich - $46K in TENX purchases and sales in the last 12 months
- June Sherie Almenoff - $15K in TENX purchases and sales in the last 12 months
- Thomas R. Staab II - $11K in TENX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christopher Thomas Giordano?
Christopher Thomas Giordano is a corporate insider, tracked as CEO, Director of TENAX THERAPEUTICS, INC. (TENX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Christopher Thomas Giordano submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Christopher Thomas Giordano been buying or selling stock?
Recorded transactions: 5 open-market purchases ($40K) and 0 open-market sales across all tracked filings.
